Miriam Kidron - 28 Jul 2022 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Chief Scientific Officer, Director
Signature
/s/Miriam Kidron
Issuer symbol
ORMP
Transactions as of
28 Jul 2022
Net transactions value
$0
Form type
4
Filing time
01 Aug 2022, 20:00:54 UTC
Previous filing
05 Jan 2022
Next filing
15 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +34,000 +19% 217,666 28 Jul 2022 Direct F1
transaction ORMP Common Stock Award +84,000 +39% 301,666 28 Jul 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock granted by the Issuer that vested on August 1, 2022.
F2 Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 28,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.